October 4, 2010 – Long-term data from a clinical trial studying the benefits of implantable cardioverter defibrillator (ICD) therapy have been published in Circulation.

October 1, 2010 – The Bradenton Cardiology Center is the first clinic in the United States to implant a peripheral self-expanding stent as part of the OSPREY study. The trial, which is evaluating the safety and efficacy of Terumo’s Misago stent system in the superficial femoral artery (SFA), will simultaneously enroll patients in the United States and Japan.

October 1, 2010 – A new Medicare-reimbursable stress test module has been launched that can assess the risk of sudden cardiac arrest. The Microvolt T-Wave Alternans (MWTA) module, by Cardiac Science, integrates with the company’s Quinton Q-Stress cardiac stress systems.

October 1, 2010 – The maker of a biodegradable stent has brought in $8.5 million during a new round of venture financing from existing investors. Arterial Remodeling Technologies (ART) now has $17 million in total investment from Matignon Technologies, Amundi Private Equity Funds and InnoBio Fund managed by CDC Enterprises.


October 1, 2010 – The most recent clinical data from USpella, a U.S. multicenter, observational registry of patients who received percutaneous cardiac support from the Impella 2.5 device, was released at TCT 2010 last week.

October 1, 2010 – The U.S. Food and Drug Adminstration (FDA) Center for Drug Evaluation and Research (CDER) has awarded two contracts to support the agency’s review of cardiac safety data. Both contracts were given to Mortara Instrument.

October 1, 2010 – An early-warning system for detecting coronary occlusion has received the CE mark for commercial sale in Europe. The AngelMed Guardian System, by Angel Medical Systems, is designed to detect coronary occlusion from thrombotic events, such as plaque ruptures, and alert the patient, often before any symptoms occur.

September 30, 2010 – New angiography navigation tools for structural heart cases were shown by GE Healthcare during last week's Transcatheter Cardiovascular Therapeutics (TCT) 2010 symposium.

September 30, 2010 – A specialized partner program was recently launched to enable select top healthcare institutions to provide advanced training in hemodynamic support and complex patient management.

September 30, 2010 – The U.S. Food and Drug Administration (FDA) has cleared a software interface and image segmentation system that can help simulate and evaluate surgical treatment options.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now